The natural history of steroid-naïve eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years

Gastrointestinal Endoscopy

Volumn 80, Issue 4, 2014, Pages 592-598

  Lipka, Seth ^a   Keshishian, Jonathan ^a   Boyce, H Worth ^a   Estores, David ^a   Richter, Joel E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BARRETT ESOPHAGUS; COHORT ANALYSIS; CONGENITAL ESOPHAGEAL STENOSIS; DYSPHAGIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL BOUGIE; ESOPHAGEAL DILATION; ESOPHAGOSCOPY; ESOPHAGUS BALLOON; ESOPHAGUS BIOPSY; ESOPHAGUS DILATATION; ESOPHAGUS DISEASE; ESOPHAGUS OBSTRUCTION; ESOPHAGUS PERFORATION; ESOPHAGUS STENOSIS; FEMALE; FOLLOW UP; FOOD IMPACTION; HIATUS HERNIA; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MALONEY BOUGIE; MUCOSAL TEAR; NON VASCULAR GUIDE WIRE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAVARY GUILLIARD BOUGIE; THORACOTOMY; THORAX PAIN; TREATMENT RESPONSE; ADOLESCENT; COMPLICATION; DILATATION; ESOPHAGEAL STENOSIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; COMBINED MODALITY THERAPY; DILATATION; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL STENOSIS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84922445976     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2014.02.012     Document Type: Article

References (41)

1. Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology 1978;74:1298-301.
2. Hruz P, Straumann A, Bussmann C, et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study. J Allergy Clin Immunol 2011;128:1349-50.e5.
3. Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over the decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009;7:1055-61.
4. Liacouras C, Furuta G, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128:3-20.
5. Kapel RC, Miller JK, Torres C, et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008;134:1316-21.
6. Bohm M, Malik Z, Sebastiano C, et al. Prevalence and racial/ethnic differences in symptoms and endoscopic findings in adults over 10 years in an urban hospital. J Clin Gastroenterol 2012;46:567-74.
7. Attwood SE, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia: a distinct clinicopathologic syndrome. Dig Dis Sci 1993;38:109-16.
8. Straumann A, Spichtin HP, Bernoulli R, et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings [In German with English abstract]. Schweiz Med Wochenschr 1994;124:1419-29.
9. Liacouras CA. Clinical presentation and treatment of pediatric patients with eosinophilic esophagitis. Gastroenterol Hepatol 2011;7:264-7.
10. Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009;137:1238-49.
11. Miller SM, Goldstein JL, Gerson LB, et al. Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD. Am J Gastroenterol 2011;106:1439-45.
12. Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003;125:1660-9.
13. DeBrosse CW, Franciosi JP, King EC, et al. Long-term outcomes in pediatric-onset esophageal eosinophilia. J Allergy Clin Immunol 2011;128:132-8.
14. Menard-Katcher P, Marks KI, Liacouras CA, et al. The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. Aliment Pharmacol Ther 2013;37:114-21.
15. Assa'adAH, Putnam PE, ColllinsMH, et al. Pediatric patientswith eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 2007;119:731-8.
16. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005;3:1198-206.
17. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009;48:30-6.
18. Straumann A, Aceves S, Blanchard C, et al. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012;67:477-90.
19. Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013;108:679-92.
20. Morrow JB, Vargo JJ, Goldblum JR, et al. The ringed esophagus: histological features of GERD. Am J Gastroenterol 2001;96:984-9.
21. Keshishian J, Vrcel V, Boyce HW, et al. Eosinophilic esophagitis: a paradigm shift for pathology. J Clin Gastroenterol. Epub 2013 Sep 25.
22. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342-63.
23. Bohm ME, Richter JE. Oesophageal dilation in adults with eosinophilic oesophagitis. Aliment Pharmacol Ther 2011;33:748-57.
24. Almansa C, Stark M, DeVault K, et al. Eosinophilic esophageal infiltration in PPI response versus steroid responsive patients: Are there phenotypic differences? Gastroenterol 2010;138:S-172.
25. Fox VL. Eosinophilic esophagitis: endoscopic findings. Gastrointest Endosc Clin North Am 2008;18:45-57.
26. Schoepfer A, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation, in a time-dependent manner. Gastroenterology 2013;145:1230-6.
27. Dellon E, Kim H, McConville, et al. Eosinophilic esophagitis is a progressive fibrostenotic disease: insights from a phenotypic analysis. Gastroenterol 2013;144:S-485.
28. Aceves SS, Ackerman SJ. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am 2009;29:197-211.
29. Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol 2008;6:165-73.
30. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006;131:1381-91.
31. Straumann A, Conus S, Degen L, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011;9:400-9.
32. Helou EF, Simonson J, Arora AS. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol 2008;103:2194-9.
33. Kelly HW, Sternberg AL, Lescher R, et al. Effect of inhaled glucocorticoids on adult height. N Engl J Med 2012;367:904-12.
34. Kavitt R, Penson D, Vaezi M. Dilate or medicate? A decision analysis of initial treatment strategies in eosinophilic esophagitis. Gastroenterol 2012;142:S-434.
35. Schoepfer AM, Gonsalvs N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 2010;105:1062-70.
36. Bohm M, Richter JE, Kelsen S, et al. Esophageal dilation: simple and effective treatment for adults with eosinophilic esophagitis and esophageal rings and narrowing. Dis Esophagus 2010;23: 377-85.
37. Goldschmid S, Boyce HW Jr, Brown JI, et al. A new objective measurement of esophageal lumen patency. Am J Gastroenterol 1989;84: 1255-8.
38. Schoepfer AM, Gschossmann J, Scheurer U, et al. Esophageal strictures in adult eosinophilic esophagitis: dilation is and effective and safe alternative after failure of topical steroids. Endoscopy 2008;40: 161-4.
39. Moawad FJ, Cheatham JG, DeZee KJ. Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis. Aliment Pharamcol Ther 2013;38:713-20.
40. Spechler SJ, Genta R, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007;102:1301-6.
41. Schoepfer A, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation, in a time-dependent manner. Gastroenterology 2013 Aug 13 (in press).